A prospective, observational study to assess the dose of enteral protein delivered to critically ill adults as standard practice across intensive care units in Australia and New Zealand.

Intensive Care Research, Royal Adelaide Hospital.0 个研究点目标入组 119 人开始时间: 2020年1月8日最近更新: 2022年8月9日

适应症

试验速览

暂无简介。

•1. Aged 18 years or older.
•2. Receiving invasive mechanical ventilation.
•3. About to commence enteral nutrition (EN) or EN commenced within the preceding 12 hours.

•1. Expected to be receiving oral nutrition within 24 hours of inclusion.
•2. Have received EN or parenteral nutrition (PN) for >12 hours in the ICU admission.
•3. Death is deemed to be imminent or inevitable during this admission and either the attending doctor, patient or substitute decision maker is not committed to active treatment
•4. The patient has an underlying disease that makes survival to 90 days unlikely
•5. The patient has a condition in which the treating clinician believes that administration of a very large or small amount of protein (e.g. large burn injury or urea cycle disorder respectively) is indicated.

发起方

Intensive Care Research, Royal Adelaide Hospital.